# Shenzhen Weigong Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-weigong-technology

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.wellgrowtec.com
- Total disclosed funding: $15M
- Latest round: Series B (Jan 25, 2022)
- Investors on record: 7

## About

Based in Shenzhen, China and established in 2016, Shenzhen Weigong Technology is a company that engages in research and development of in-vitro diagnostic reagents and medical equipment. The company has three subsidiaries in Shenzhen, Beijing, and Hunan that the subsidiary in Beijing is R&D center, and other subsidiaries are production base. The company's founder is Dr. Weigong Li, who served in the company of BCI, and  SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD, and has R&D of experience in blood cell analysis instrument, and flow analysis instrument. 

The company mainly provides flow cytometry automated equipment and high-throughput fluorescence immunoassay technology. The company's high-throughput fluorescence immunoassay technology can support simultaneously testing over 100 test items in one test tube. It also provides supporting lymphocyte subsets, cytokines, sperm function testing reagents, and client software with automatic analysis functions and two-way information transmission functions.

As of January 2022, the company is developing a universal automatic fluorescence immunoassay analyzer with a detection speed of at least 1200 items per hour. It is expected to be available in the first half of 2022. Moreover, the company will promote the detection 
 of autoimmune diseases, and allergens from qualitative to quantitative detection.

## Funding rounds

- Series B, Jan 25, 2022 — Cowin Capital, China Merchants Health Industry Holdings
- Series B, Jul 16, 2021, $15M — Cowin Capital, YuanBio Venture, Vinno Capital, Zhongguancun Development Venture
- Series A, Dec 30, 2019 — Green Pine Capital Partners, Vinno Capital
- Angel, Dec 22, 2017 — Share Capital, Vinno Capital

## Investors

- Share Capital (https://capitalatlas.ai/funds/share-capital) — Angel
- Vinno Capital (https://capitalatlas.ai/funds/vinno-capital) — Angel, Series A, Series B
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series B
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B
- Zhongguancun Development Venture (https://capitalatlas.ai/funds/zhongguancun-development-venture) — Series B
- China Merchants Health Industry Holdings — Series B